JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okita, G. T.
Right arrow Articles by Kelsey, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okita, G. T.
Right arrow Articles by Kelsey, F. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 110, Issue 2, 244-250, 1954
Copyright © 1954 by American Society for Pharmacology and Experimental Therapeutics


BIOSYNTHESIS AND ISOLATION OF CARBON-14 LABELED DIGITOXIN

G. T. Okita 1, E. J. Walaszek 1, E. M. K. Geiling 1, and F. E. Kelsey 2

1 Department of Pharmacology, The University of Chicago, Chicago 37, Illinois
2 Department of Physiology and Pharmacology, The University of South Dakota, Vermillion, S. D.

A procedure has been described for the biosynthesis of radioactive digitoxin from Digitalis purpurea L. plants grown in an atmosphere of radioactive CO2. Employing the growing chamber described, it was possible to administer as much as 4.2 mc. of C14 to each plant without causing any noticeable inhibition in growth rate when compared to control plants grown simultaneously in a second chamber under similar conditions, but without the labeled CO2. However, histological studies of radioactive plant leaves (Beal, 1949) indicate that C14 does cause injury to the plant leaves. It is believed that larger amounts of C14 can be administered to the plants although this has not yet been attempted.

An extraction procedure for the labeled drug utilizing chemical and chromatographic methods has also been described. The yield of non-crystalline digitoxin was approximately 0.06 per cent: after crystallization the yield was reduced to approximately 0.04 per cent. Depending upon the amount of C14 administered, the specific activity of the labeled glycoside ranged from 0.26 to 0.54 µc. per milligram. This range of specific activity was found to be sufficient for biological tracer studies.

Using the radioactive method of assay and adding non-labeled carrier digitoxin to the biological sample, it is possible to isolate and detect as little as 0.02 microgram of radioactive digitoxin (original sp. activity—0.537 µc./mgm.) per 100 ml. of human urine.

Identification tests performed on the radioactive drug indicated that the isolated compound was digitoxin of high purity.

Submitted on October 10, 1953







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1954 by the American Society for Pharmacology and Experimental Therapeutics.